Patient Guide: Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 57 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT03238326
Status: ACTIVE_NOT_RECRUITING
Condition: Schizophrenia
Phase: PHASE3

Where You Can Participate

This study is available at 57 locations across the country.

Top locations include:
  • • Dothan, Alabama
  • • Anaheim, California
  • • Culver City, California
  • • And 54 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia - Join Clinical Trial NCTNCT03238326

How to Join This Clinical Trial - NCTNCT03238326

Learn how to participate in this PHASE3 trial studying an investigational therapy for Schizophrenia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Schizophrenia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Schizophrenia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT03238326 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 57 locations. Find a study site near you:

Clinical Research Site

Dothan, Alabama 36303 - United States

Status: Contact for availability

Clinical Research Site

Anaheim, California 92805 - United States

Status: Contact for availability

Clinical Research Site

Culver City, California 90230 - United States

Status: Contact for availability

Clinical Research Site

Long Beach, California 90807 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30331 - United States

Status: Contact for availability

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: Contact for availability

Clinical Research Site

Lake Charles, Louisiana 70629 - United States

Status: Contact for availability

Clinical Research Site

Las Vegas, Nevada 89109 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10036 - United States

Status: Contact for availability

Clinical Research Site

Rochester, New York 14618 - United States

Status: Contact for availability

And 47 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Schizophrenia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships